Liver and preeclampsia;Foie et prééclampsie

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 4, 2010, Pages

  Ducarme, G ^a   Bernuau, J ^a   Luton, D ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Acute steatosis and pregnancy; HELLP syndrome; Liver and pregnancy; Preeclampsia

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; FIBRIN; LIVER ENZYME; PLACEBO;

AMENORRHEA; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; EPIGASTRIC PAIN; FATTY LIVER; GASTROINTESTINAL PAIN; HELLP SYNDROME; HEMODYNAMICS; HEMOLYSIS; HUMAN; INCIDENCE; LIVER SINUSOID; MITOCHONDRIAL RESPIRATION; PLASMAPHERESIS; POLYDIPSIA; POLYURIA; PREECLAMPSIA; PREGNANCY; THROMBOCYTOPENIA;

ADULT; FATTY LIVER; FEMALE; HELLP SYNDROME; HUMANS; LIVER; LIVER CIRCULATION; LIVER DISEASES; MATERNAL MORTALITY; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY;

EID: 77952881179     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.02.024     Document Type: Article

References (74)

1. Bernuau J. Foie et grossesse. Traité d'Obstétrique 2003, 609-616. Flammarion Médecine-Sciences, Paris. D. Cabrol, J.C. Pons, F. Goffinet (Eds.).
2. Fagan E.A. Disorders of the liver, biliary system and pancreas. Medical disorders in obstetric practice 2002, 282-345. Blackwell Science, Oxford. fourth edition. M. de Swiet (Ed.).
3. Sibai B.M., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
4. Tuffnell D.J., Jankowicz D., Lindow S.W., Lyons G., Mason G.C., Russell I.F., et al. Outcomes of severe preeclampsia/eclampsia in Yorshire 1999/2003. BJOG 2005, 112:875-880.
5. Ch'ng C.L., Morgan M., Hainsworth I., Kingham J.G. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002, 51:876-880.
6. Barton J.R., Riely C.A., Adamec T.A., Shanklin D.R., Khoury A.D., Sibai B.M. Hepatic histopathology condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1992, 167:1538-1543.
7. Sibai B.M., Ramadan M.K., Usta I., Salama M., Mercer B.M., Friedman S.A. Maternal morbidity and mortality in 442 pregnancies with hemolysis elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993, 169:1000-1006.
8. Martin J.N., Rinehart B.K., May W.L., Magann E.F., Terrone D.A., Blake P.G. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzymes levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999, 180:1373-1384.
9. Sibai B.M., Taslimi M.M., El-Nazer A., Amon E., Mabie B.C., Ryan G.M. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986, 155:501-509.
10. Haddad B., Barton J.R., Livingston J.C., Chahine R., Sibai B.M. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000, 183:444-448.
11. Haddad B., Barton J.R., Livingston J.C., Chahine R., Sibai B.M. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at ≤28.0 weeks'gestation. Am J Obstet Gynecol 2000, 183:1475-1479.
12. Baumwell S., Karumanchi S.A. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 2007, 106:c72-c81.
13. Arias F., Mancilla-Jimenez R. Hepatic fibrinogen deposits in pre-eclampsia. Immunofluorescent evidence. N Engl J Med 1976, 295:578-582.
14. Costentin L., Zafrani E.S., Dhumeaux D., Mallat A. Constitution rapide de calcifications intra-hépatiques au décours d'un syndrome HELLP. Gastroenterol Clin Biol 2002, 26:802-803.
15. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142:159-167.
16. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004, 103:981-991.
17. Tomsen T.R. HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) presenting as generalized malaise. Am J Obstet Gynecol 1995, 172:1876-1878.
18. Cavkaytar S., Ugurlu E.N., Karaer A., Tapisiz O.L., Danisman N. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome?. Acta Obstet Gynecol Scand 2007, 86:648-651.
19. O'Brien J.M., Barton J.R. Controversies with diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 2005, 48:460-477.
20. Audibert F., Friedman S.A., Frangieh A.Y., Sibai B.M. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996, 175:460-464.
21. Collinet P., Delemer-Lefebvre M., Dharancy S., Lucot J.P., Subtil D., Puech F. Le HELLP syndrome: diagnostic et prise en charge thérapeutique. Gynecol Obstet Fertil 2006, 34:94-100.
22. Nakai A., Sekyia I., Oya A., Koshino T., Araki T. Assessment of hepatic arterial and portal venous blood flows during pregnancy with Doppler ultrasonography. Arch Gynecol Obstet 2002, 266:25-29.
23. Oosterhof H., Voorhoeve P.G., Aarnoudse J.G. Enhancement of hepatic artey blood flow in preeclampsia in presence or absence of HELLP syndrome ((hemolysis, elevated liver enzymes, and low platelets). Am J Obstet Gynecol 1994, 171:526-530.
24. Kawabata I., Nakai A., Takeshita T. Prediction of HELLP syndrome with assessment of maternal dual hepatic blood supply by using Doppler ultrasound. Arch Gynecol Obstet 2006, 274:303-309.
25. Sibai B.M. Imitators of severe preeclampsia. Obstet Gynecol 2007, 109:956-966.
26. Aarnoudse J.G., Houthoff H.J., Weits J., Vellenga E., Huisjes H.J. A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy. A clinical and histopathological study. Br J Obstet Gynaecol 1986, 93:145-155.
27. Barton J.R., Sibai B.M. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004, 31:807-833.
28. Magann E.F., Martin J.N. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 1999, 42:532-550.
29. Tompkins M.J., Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 1999, 181:304-309.
30. O'Brien J.M., Milligan D.A., Barton J.R. Impact of high dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000, 183:921-924.
31. Isler c.m., Barrilleaux P.S., Magann E.F., Bass D., Martin J.N. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP syndrome. Am J Obstet Gynecol 2001, 184:1332-1339.
32. Matchaba P., Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 2004, 1:CD002076.
33. Fonseca J.E., Mendez F., Catano C., Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double blind, placebo controlled, randomized clinical trial. Am J Obstet Gynecol 2005, 193:1591-1598.
34. van Runnard Heimel P.J., Huisjes A.J., Franx A., Koopman C., Bots M.L., Bruinse H.W. A randomised placebocontrolled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet Gynecol Reprod Biol 2006, 128:187-193.
35. Visser W., Wallenburg H.C.S. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995, 102:111-117.
36. Haddad B., Louis-Sylvestre C., Doridot V., Touboul C., Abirached F., Paniel P.J. Critères d'extraction fœtale dans la prééclampsie. Gynecol Obstet Fertil 2002, 30:467-473.
37. Barton J.R., Sibai B.M. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1996, 174:1820-1827.
38. Gadwood .K.A., Reynes C.J., Flisak M.E., Gianopoulos J., Tomich P., Karlman R. Gallbladder wall thickening in preeclampsia. JAMA 1985, 253:71-73.
39. Manas K.J., Welsh J.D., Rankin R.A., Miller D.D. Hepatic hemorrhage without rupture in preeclampsia. N Engl J Med 1985, 312:424-426.
40. Gordon S.C. Budd-Chiari and infarct in pregnancy. Clin Liver Dis 1999, 3:97-113.
41. Barton J.R., Sibai B.M. HELLP and the liver diseases of preeclampsia. Clin Liver Dis 1999, 3:31-48.
42. Carlson K.L., Bader C.L. Ruptured subcapsular liver hematoma in pregnancy: a case report of nonsurgical management. Am J Obstet Gynecol 2004, 190:558-560.
43. Gilboa Y., Bardin R., Feldberg Bachar G.N. Postpartum hepatic rupture and retroperitoneal hematoma associated with HELLP syndrome. IMAJ 2006, 8:219-220.
44. Terasaki K.K., Quinn M.F., Lundell C.J., Finck E.J., Pentecost M.J. Spontaneous hepatic haemorrhage in preeclampsia: treatment with hepatic arterial embolization. Radiology 1990, 174:1039-1041.
45. Bernuau J., Rangheard A.S., Seince P.F., Deval B., Durand F., Levardon M., et al. Spontaneous capsular rupture (SCR) of the liver: non-invasive early management in preeclamptic delivered women with massive hepatic subcapsular hematoma (SCH). Hepatology 2002, 36:721A.
46. Smith L.G., Moise K.J., Dildy G.A., Carpenter R.J. Spontaneous rupture of liver during pregnancy: current therapy. Obstet Gynecol 1991, 77:171-175.
47. Reck T., Bussenius-Kammerer M., Ott R., Müller V., Beinder E., Hohenberger W. Surgical treatment of HELLP syndrome-associated liver rupture - an update. Eur J Obstet Gynecol Reprod Biol 2001, 99:57-65.
48. Zarrinpar A., Farmer D.G., Ghobrial R.M., Lipshutz G.S., Gu Y., Hiatt J.R., et al. Liver transplantation for HELLP syndrome. Am Surg 2007, 73:1013-1016.
49. Sakala E.P., Moore W.D. Successful delivery after previous pregnancy with ruptured liver. Obstet Gynecol 1986, 68:124-126.
50. Magann E.F., Bass D., Chauhan S.P., Sullivan D.L., Martin R.W., Martin J.N. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994, 171:1148-1153.
51. Magann E.F., Perry K.O., Meydrech E.F., Harris R.L., Chauhan S.P., Martin J.N. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994, 171:1154-1158.
52. Vigil-DeGracia P., Garcia-Caceres E. Dexamethasone in the postpartum treatment of HELLP syndrome. Int J Gynaecol Obstet 1997, 59:217-221.
53. Yalcin O.T., Sener T., Hassa H., Ozalp S., Okur A. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynaecol Obstet 1998, 61:141-148.
54. Martin J.N., Perry K.G., Blake P.G., May W.A., Moore A., Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 1997, 177:1011-1017.
55. Martin J.N., Perry K.G., Roberts W.E., Files J.C., Norman P.H., Morrison J.C., et al. Plasma exchange for preeclampsia: III. Immediate peripartal utilization for selected patients with HELLP syndrome. J Clin Apheresis 1994, 9:162-165.
56. Martin J.N., Files J.C., Blake P.G., Perry K.G., Morrison J.C., Norman P.H. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1995, 172:1107-1127.
57. Eser B., Guven M., Unal A., Coskun R., Altuntas F., Sungur M., et al. The role of plasma exchange in HELLP syndrome. Clin Appl Thromb Hemost 2005, 11:211-217.
58. Bayraktaroglu Z., Demirci F., Balat O., Kutlar I., Okan V., Ugur G. Plasma exchange therapy in HELLP syndrome: a single-center experience. Turk J Gastroenterol 2006, 17:99-102.
59. Del Fante C., Perotti C., Viarengo G., Gallini G.S., Tinelli C., Salvaneschi L. Daily plasma-exchange for lifethreatening class I HELLP syndrome with prevalent pulmonary involvement. Transfus Apher Sci 2006, 34:7-9.
60. Förster J.G., Peltonen S., Kaaja R., Lampinen K., Pettilä V. Plasma exchange in severe HELLP syndrome. Acta Anaesthesiol Scand 2002, 46:955-958.
61. Martin J.N., Blake P.G., Lowery S.L., Perry K.G., Files J.C., Morrison J.C. Pregnancy complicated by preeclampsia-eclampsia with HELLP syndrome: how rapid is postpartum recovery?. Obstet Gynecol 1990, 76:737-741.
62. Katz V.L., Thorp J.M., Rozas L., Bowes W.A. The natural history of thrombocytopenia associated with preeclampsia. Am J Obstet Gynecol 1990, 163:1142-1143.
63. Neiger R., Contag S.A., Coustan D.R. The resolution of preeclampsia related thrombocytopenia. Obstet Gynecol 1991, 77:692-695.
64. Makkonen N., Harju M., Kirkinen P. Postpartum recovery after severe preeclampsia and HELLP syndrome. J Perinat Med 1996, 24:641-649.
65. Browning M.F., Levy H.L., Wilkins-Haug L.E., Larson C., Shik V.E. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006, 107:115-120.
66. Ylitalo K., Vänttinen T., Halmasmäki E., Tyni T. Serious pregnancy complications in a patient with previously undiagnosed carnitine palmitoyltransferase 1 deficiency. Am J Obstet Gynecol 2005, 192:2060-2062.
67. Treem W.R.., Shoup M.E., Hale D.E., Bennett M.J., Rinaldo P., Millington D.S., et al. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, a nd long chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency. Am J Gastroenterol 1996, 91:2293-2300.
68. Ibdah J.A., Bennett M.J., Rinaldo P., Zhao Y., Gibson B., Sims H., et al. A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999, 340:1723-1731.
69. Ibdah J.A., Yang Z., Bennett M.J. Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Gen Metabol 2000, 71:182-189.
70. den Boer M.E., Ijist L., Wijburg F.A., Oostheim W., van Werkhoven M.A., van Pampus M.G., et al. Heterozygosity for the common LCHAD mutation (1528g>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 2000, 48:151-154.
71. Yang Z., Yamada J., Zhao Y., Strauss A.W., Ibdah J.A. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 2002, 228:2163-2166.
72. Holub M., Bodamer O.A., Item C., Mühl A., Pollak A., Stôckler-Ipsiroglu S. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome?. Acta Paediatr 2005, 94:48-52.
73. Wang R., Yang Z., Zhu J.M., Wang J.L., Yang H.X., Wang Q., et al. Screening for G1528C mutation in mitochondrial trifunctional protein gene in pregnant women with severe preeclampsia and new born infant. Zhonghua Fu Chan Ke Za Zhi 2006, 41:672-675.
74. Mütze S., Ahillen I., Rudnik-Schoeneborn S., Eggermann T., Leeners B., Neumaier-Wagner P.M., et al. Neither maternal nor fetal mutation (E474Q) in the alpha-subunit of the trifunctional protein is frequent in pregnancies complicated by HELLP syndrome. J Perinat Med 2007, 35:76-78.